Forget Pot? This $3 Medical Device Stock Could Be Worth $9 With Right Execution

- Marijuana de-regulation in Canada, and parts of the U.S., has given rise to the marijuana industry, and many of these publicly traded companies have performed well as a result - A comparable regulatory change in the U.S. with remote patient monitoring has been mostly off the radar of investors. Two early entrants in this market have generated big returns for investors. IRTC traded from $17 to $80/share and BEAT from $2 to $40/share - New entrant Biotricity (BTCY) is jumping into the same market ... Click here to view full article